Galderma

Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments. The company became a wholly owned subsidiary of Nestlé in 2014.

Galderma provides a range of products used to treat acne, rosacea, psoriasis and other steroid-responsive dermatoses (SRD), onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and skin senescence. Galderma’s products sell in more than 70 countries.

Galderma is the medical solutions brand within Nestlé Skin Health. Given the important role our skin plays in our daily lives, we focus on science-based solutions that will enhance the quality of people’s lives.

The Code of Ethics is an explicit declaration of adherence to the highest ethical standards in our work. It states that it is the responsibility of every employee to “do the right thing, the right way” to ensure the highest standards of integrity. It means that when we create value for our company and its stakeholders, such as the people and communities we serve, we should do so by acting in an ethical and socially responsible way. The Code reflects the values and behavior that have strongly contributed to making us successful over the years.

Galderma provides both prescription drugs and aesthetic solutions, treating compromised skin, enhancing healthy skin, and providing solutions for aging skin.

For over 35 years, Galderma has partnered with healthcare professionals and academia across the globe to find innovative solutions to skin issues and deliver safe and effective treatments to meet the skin health needs of people throughout their lifetimes.

Galderma provides prescription drugs and aesthetic solutions, going beyond treating skin problems to enhance healthy skin, treat compromised skin and rejuvenate aging skin. Galderma also offers over-the-counter products, providing consumers with the solutions they need to maintain healthy skin throughout their lives.

Today, dermatology is receiving a growing amount of recognition and attention. As we are living longer, caring for our skin as we age is also becoming increasingly important. Galderma is spearheading this change in the world’s outlook on skin health.

As a focused dermatology company right from the start, Galderma is committed to the healthcare community, providing education and training programs as well as ongoing support to healthcare professionals throughout their career, to enable them to remain at the forefront of their field.

Today, Galderma’s product portfolio is available in more than 100 countries, offering treatment for a range of dermatological conditions. In the United States, our portfolio includes aesthetic solutions as well as treatments for acne, rosacea, steroid-responsive dermatoses and melasma, and over-the-counter solutions for consumers.